Correction: A ROS-scavenging multifunctional nanoparticle for combinational therapy of diabetic nephropathy
نویسندگان
چکیده
Correction for ‘A ROS-scavenging multifunctional nanoparticle combinational therapy of diabetic nephropathy’ by Yuna Tong et al., Nanoscale, 2020, DOI: 10.1039/d0nr06098d.
منابع مشابه
Correction: Suramin: A Potential Therapy for Diabetic Nephropathy
The second author’s name is spelled incorrectly. The correct name is: Lauren A. Howell. The correct citation is: Korrapati MC, Howell LA, Shaner BE, Megyesi JK, Siskind LJ, et al. (2013) Suramin: A Potential Therapy for Diabetic Nephropathy. PLoS ONE 8(9): e73655. doi:10.1371/journal.pone.0073655 The Author Contributions should read: Conceived and designed the experiments: MCK LJS RGS. Performe...
متن کاملNew modalities for treatment of diabetic nephropathy: a mini review
Background and aims: Diabetic nephropathy (DN) is the most common cause of end-stage renal failure which could increase the risk of cardiovascular disease and morbidity and mortality in patients. The aim of this study was to investigate new modalities for treatment of diabetic nephropathy. Methods:This study was a mini-review research to investigate drugs that are used for DN treatment. Resul...
متن کاملAntiangiogenic Therapy for Diabetic Nephropathy
Angiogenesis has been shown to be a potential therapeutic target for early stages of diabetic nephropathy in a number of animal experiments. Vascular endothelial growth factor (VEGF) is the main mediator for abnormal angiogenesis in diabetic glomeruli. Although beneficial effects of anti-VEGF antibodies have previously been demonstrated in diabetic animal experiments, recent basic and clinical ...
متن کاملA Novel Therapy for Diabetic Nephropathy
Citation: Woo KT, Chan CM, Choong HL, (2017) A Novel Therapy for Diabetic Nephropathy. J Nephrol urol. Vol. 1 No. 1: 2 The ISN (International Society of Nephrology) Global Outreach Programme confirmed that for the less developed countries, compared to the more developed ones, Chronic Glomerulonephritis (Chronic GN) and not Diabetic Nephropathy (DiabNx) is still the leading cause of end stage re...
متن کاملSuramin: A Potential Therapy for Diabetic Nephropathy
OBJECTIVE To determine whether delayed administration of a single dose of suramin, a drug that has been used extensively in humans to treat trypanosomiasis, attenuates renal injury in a leptin receptor deficient C57BLKS/J db/db type 2 diabetic nephropathy (T2DN) mouse model. RESEARCH DESIGN AND METHODS Groups of female non-diabetic (control) db/m and diabetic db/db mice of 8 and 16 weeks of a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nanoscale
سال: 2021
ISSN: ['2040-3372', '2040-3364']
DOI: https://doi.org/10.1039/d0nr90283g